{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:23:40Z","timestamp":1771007020902,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.numecd.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T19:45:29Z","timestamp":1345146329000},"page":"836-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adverse myocardial effects of B-vitamin therapy in subjects with chronic kidney disease and hyperhomocysteinaemia"],"prefix":"10.1016","volume":"23","author":[{"given":"Z.","family":"Rafeq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2012.07.002_bib1","first-page":"111","article-title":"Vascular pathology of hyperhomocysteinemia: implications for the development of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Path"},{"key":"10.1016\/j.numecd.2012.07.002_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intake","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2012.07.002_bib3","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2012.07.002_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2012.07.002_bib5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.numecd.2012.07.002_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.numecd.2012.07.002_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease. A randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2012.07.002_bib8","doi-asserted-by":"crossref","first-page":"H2567","DOI":"10.1152\/ajpheart.00475.2002","article-title":"Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats","volume":"283","author":"Joseph","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2012.07.002_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.carpath.2005.11.001","article-title":"Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats","volume":"15","author":"Devi","year":"2006","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.numecd.2012.07.002_bib10","first-page":"175","article-title":"Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat","volume":"34","author":"Walker","year":"2004","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.numecd.2012.07.002_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ehj.2004.01.008","article-title":"Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study","volume":"25","author":"Sundstrom","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2012.07.002_bib12","first-page":"248","article-title":"Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease","volume":"12","author":"Blacher","year":"1999","journal-title":"J Nephrol"},{"key":"10.1016\/j.numecd.2012.07.002_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijcard.2008.11.131","article-title":"Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome","volume":"141","author":"Maurer","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2012.07.002_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/clc.4960260904","article-title":"Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations","volume":"26","author":"Schofield","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.numecd.2012.07.002_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCHEARTFAILURE.109.899070","article-title":"Chronic kidney disease and the risk of heart failure in men","volume":"4","author":"Dhingra","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.numecd.2012.07.002_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9149(03)00822-1","article-title":"Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age","volume":"92","author":"Chae","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2012.07.002_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","article-title":"Association between serum homocysteine and markers of impaired kidney function in adults in the United States","volume":"66","author":"Francis","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2012.07.002_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1997.359","article-title":"Kinetic basis of hyperhomocyteinemia in patients with chronic renal failure","volume":"52","author":"Guttormsen","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2012.07.002_bib19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clinbiochem.2006.11.010","article-title":"The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine","volume":"40","author":"Lin","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.numecd.2012.07.002_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1515\/CCLM.2006.245","article-title":"Increased homocysteine in heart failure: a result of renal impairment?","volume":"44","author":"Aksoy","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.numecd.2012.07.002_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.289.10.1251","article-title":"Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction","volume":"289","author":"Vasan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2012.07.002_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000320106","article-title":"Homocysteine levels in patients with heart failure with preserved ejection fraction","volume":"117","author":"Okuyan","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.numecd.2012.07.002_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2012.07.002_bib24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjcard.2005.05.031","article-title":"Usefulness of left atrial volume in predicting first congestive heart failure in patients \u226565 years of age with well-preserved left ventricular systolic function","volume":"96","author":"Takemoto","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2012.07.002_bib25","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1523-1755.1999.00624.x","article-title":"Homocysteine and methionine metabolism in ESRD: a stable isotope study","volume":"56","author":"van Guldener","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2012.07.002_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000045423","article-title":"Evidence of altered homocysteine metabolism in chronic renal failure","volume":"83","author":"Henning","year":"1999","journal-title":"Nephron"},{"key":"10.1016\/j.numecd.2012.07.002_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-139X.2010.00784.x","article-title":"Inflammation in end-stage renal disease \u2013 what we have learned in 10 years?","volume":"23","author":"Carrero","year":"2010","journal-title":"Semin Dial"},{"key":"10.1016\/j.numecd.2012.07.002_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.hfc.2009.04.001","article-title":"Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders","volume":"5","author":"von Haehling","year":"2009","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.numecd.2012.07.002_bib29","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(03)13372-7","article-title":"Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia","volume":"361","author":"Ingrosso","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2012.07.002_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjcard.2010.03.064","article-title":"Meta-analysis of folic acid supplementation trial on risk of cardiovascular interaction with baseline homocysteine levels","volume":"106","author":"Miller","year":"2010","journal-title":"Am J Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475312001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475312001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T12:21:27Z","timestamp":1542802887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475312001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0939475312001731"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2012.07.002","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse myocardial effects of B-vitamin therapy in subjects with chronic kidney disease and hyperhomocysteinaemia","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2012.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}